• 제목/요약/키워드: brain imaging

검색결과 1,387건 처리시간 0.029초

소동물에서 18F-Fallypride의 비방사능에 따른 뇌의 PET이미지와 Binding Potential 차이에 대한 연구 (A study of Brain Micro-PET Imaging and Bindingpotential with a Different Specific Activity of 18F-Fallypride in the Small Animal)

  • 조규상;안성민
    • 한국콘텐츠학회논문지
    • /
    • 제15권9호
    • /
    • pp.418-424
    • /
    • 2015
  • 본 연구에서는 비방사능 값에 따른 소동물 in vivo실험에서 어느 정도의 비방사능에서부터 수용체-리간드의 결합능력의 변화와 선조체에서의 방사능 집적에 변화가 있는지를 규명하고자 실험을 진행하다. 18F-Fallypride을 3가지 값 ; 높은 비방사능 : 43.29~74 GBq/umol, 중간 비방사능 : 20.72~29.23 GBq/umol, 낮은 비방사능 : 6.29~8.51 GBq/umol)으로 나누어 순차적으로 혈관주사 후 Micro PET을 이용하여 90분 동적 스캔 하였다. 스캔 후 양쪽 선조체에서 Binding Potential(BP)을 구한 후 비교 분석하였다. 높은 비방사능과 낮은 비방사능, 중간 비방사능과 낮은 비방사능에서 유의한 차이가 나타났다. 또한 18F-Fallypride을 이용한 PET 영상비교에서는 높은 비방사능과 중간 비방사능에서는 선조체 에서 높은 방사능집적을 보여주었지만, 낮은 비방사능에서는 다른 두 비방사능에 비해 낮은 방사능 집적을 볼 수 있었다. 이는 18F-Fallypride의 약동학적 특성상 D2/D3에 대한 친화성이 좋기 때문에 비방사능 값이 어느 정도 떨어진 상태에서도 BP의 차이가 크지 않았다. 하지만 높은 비방사능에 비해 6.5배 낮은 비방사능 값 부터는 이미지 및 BP의 차이가 유의하게 나왔으므로 앞으로 18F-Fallyprdie을 이용한 선조체 PET연구에서는 이를 고려하여 실험 할 필요가 있을 것이다.

특이값 분해 기반 Dynamic PET 영상의 노이즈 제거 기법 : 예비 연구 (Singular Value Decomposition based Noise Reduction Technique for Dynamic PET I mage : Preliminary study)

  • 편도영;김정수;백철하;정영진
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제39권2호
    • /
    • pp.227-236
    • /
    • 2016
  • 동적 양전자방출단층 촬영은 3차원의 공간적 정보와 추가적인 1차원의 시계열 정보가 함께 존재하는 시공간 정보(4차원)의 데이터를 활용할 수 있어서 전통적인 영상기법에 비해 임상 진단 및 분석에 활용할 수 있는 정보의 양이 급격히 증가된 의료영상 촬영기법이다. 그러나, 인체에 주입할 수 있는 방사성 동위원소의 양의 제한 및 검출기 특징에 따른 감마선 검출의 제한 등이 영상을 재구성 하는 것에 제약사항으로 존재하여, 고화질 의료 영상의 획득에 어려움이 존재하여 임상적 활용의 제한사항이 되어왔다. 본 연구에서는, 4차원 영상의 적극적인 임상 활용을 위해서 영상의 화질을 개선하고 정량적인 평가를 할 수 있는 영상 기법을 연구하였다. 이를 위해, Matlab을 이용하여 영상의 여러 독립적인 신호원을 분리하여 영상의 신호와 노이즈로 구분할 수 있도록, 선형 대수학의 기법 중 하나인 특이값 분해를 활용하였다. 이를 통해, 개선된 동적 양전자방출단층 영상은 정량적인 평가를 통하여, 원래 영상에 비해 SNR이 최소 5%에서 최대 30%까지 증가하는 것을 확인하였다. 이러한 연구 결과는 향후 dynamic PET 연구의 기초적인 도구로 활용될 것이라 기대된다.

주요우울장애 환자에서 소뇌 국소 부위의 부피와 피질 두께의 차이 (Changes in the Volume and Cortical Thickness of the Specific Regions of Cerebellum of Patients with Major Depressive Disorder)

  • 강지원;한규만;원은수;태우석;함병주
    • 생물정신의학
    • /
    • 제25권3호
    • /
    • pp.60-71
    • /
    • 2018
  • Objectives A growing body of evidence has suggested that morphologic changes in cerebellum may be implicated with pathophysiology of major depressive disorder (MDD). The aim of this study is to investigate a difference in the volume and cortical thickness of the specific region of cerebellum between patients with MDD and healthy controls (HC). Methods A total of 127 patients with MDD and 105 HC participated in this study and underwent T1-weighted structural magnetic resonance imaging. We analyzed volume and cortical thickness of each twelve cerebellum regions divided by left and right and the volume and cortical thickness of the whole cerebellum from T1-weigted image of participants. One-way analysis of covariance was used to investigate the volume and cortical thickness difference of total and specific regions between two groups adjusting for age, gender, medication, and total intracranial cavity volume. Results We found that the patients with MDD had significantly greater volume in the left cerebellum lobule III region [false discovery rate (FDR)-corrected p = 0.034] compared to HC. Also, our findings indicate that cortical thickness of left lobule VIIB (FDR-corrected p = 0.032) and lobule VIIIB (FDR-corrected p = 0.032) are significantly thinner in the patients with MDD compared with the HC. No significant volume and cortical thickness differences were observed in other sub-regions of the cerebellum. The volumes and cortical thickness of whole cerebellum between patients with MDD and HC did not differ significantly. Conclusions We observed the region-specific volume and cortical thickness difference in cerebellum between the patients with MDD and HC. The results of our study implicate that the information about structural alterations in cerebellum with further replicative studies might provide a stepping stone toward a specific marker to diagnose MDD.

  • PDF

신경유육종증이 병발한 폐유육종증 1예 (A Case of Pulmonary Sarcoidosis Combined with Neurosarcoidosis)

  • 박병훈;박선철;신상윤;전한호;정경수;정우영;변민광;문지애;김영삼;김세규;장준;김성규;박무석
    • Tuberculosis and Respiratory Diseases
    • /
    • 제62권6호
    • /
    • pp.549-553
    • /
    • 2007
  • 유육종증은 다발성 비건락성 육아종 형성을 특징으로 하는 원인 미상의 전신 질환으로 주로 폐, 피부, 림프절 등의 장기를 침범하며, 신경계 침범은 상대적으로 드문 것으로 알려져 있다. 저자들은 다른 신경학적 증상 없이 단기 기억장애만을 특징으로 하는 신경유육종증이 병발한 폐유육종증 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

Planning and Dosimetric Study of Volumetric Modulated Arc Based Hypofractionated Stereotactic Radiotherapy for Acoustic Schwannoma - 6MV Flattening Filter Free Photon Beam

  • Swamy, Shanmugam Thirumalai;Radha, Chandrasekaran Anu;Arun, Gandhi;Kathirvel, Murugesan;Subramanian, Sai
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권12호
    • /
    • pp.5019-5024
    • /
    • 2015
  • Background: The purpose of this study was to assess the dosimetric and clinical feasibility of volumetric modulated arc based hypofractionated stereotactic radiotherapy (RapidArc) treatment for large acoustic schwannoma (AS >10cc). Materials and Methods: Ten AS patients were immobilized using BrainLab mask. They were subject to multimodality imaging (magnetic resonance and computed tomography) to contour target and organs at risk (brainstem and cochlea). Volumetric modulated arc therapy (VMAT) based stereotactic plans were optimized in Eclipse (V11) treatment planning system (TPS) using progressive resolution optimizer-III and final dose calculations were performed using analytical anisotropic algorithm with 1.5 mm grid resolution. All AS presented in this study were treated with VMAT based HSRT to a total dose of 25Gy in 5 fractions (5fractions/week). VMAT plan contains 2-4 non-coplanar arcs. Treatment planning was performed to achieve at least 99% of PTV volume (D99) receives 100% of prescription dose (25Gy), while dose to OAR's were kept below the tolerance limits. Dose-volume histograms (DVH) were analyzed to assess plan quality. Treatments were delivered using upgraded 6 MV un-flattened photon beam (FFF) from Clinac-iX machine. Extensive pretreatment quality assurance measurements were carried out to report on quality of delivery. Point dosimetry was performed using three different detectors, which includes CC13 ion-chamber, Exradin A14 ion-chamber and Exradin W1 plastic scintillator detector (PSD) which have measuring volume of $0.13cm^3$, $0.009cm^3$ and $0.002cm^3$ respectively. Results: Average PTV volume of AS was 11.3cc (${\pm}4.8$), and located in eloquent areas. VMAT plans provided complete PTV coverage with average conformity index of 1.06 (${\pm}0.05$). OAR's dose were kept below tolerance limit recommend by American Association of Physicist in Medicine task group-101(brainstem $V_{0.5cc}$ < 23Gy, cochlea maximum < 25Gy and Optic pathway <25Gy). PSD resulted in superior dosimetric accuracy compared with other two detectors (p=0.021 for PSD.

MR Technology to 4T

  • Vaughan, Thomas
    • 대한자기공명의과학회:학술대회논문집
    • /
    • 대한자기공명의과학회 2003년도 제8차 학술대회 초록집
    • /
    • pp.103-105
    • /
    • 2003
  • After fifteen years of development, Magnetic Resonance (MR) technology for human imaging and spectroscopy is reaching a refined state with FDA approved 3T clinical products from Siemens, GE, and Philips. Broker has cleared CE approval with a 4T system. Varian supports a 4T system platform as well. Shielded magnets are standard at 3T from GE, Oxford, Magnex, and IGC. A shielded 4T whole body magnet is available from Oxford. Stronger switched gradients and dynamic shim coils, desired at any field, areespecially useful at higher static magnetic fields B0. In addition to the higher currents required for higher resolution slice or volume selection afforded by higher SNR, whole body gradient coils will be driven at increasing slew rates to meet the needs of new cardiac applications and other requirements. For example 3T and 4T systems are now being equipped with 2kV, 500A gradient coils and amplifiers capable of generating 4G/cm in 200msec, over a 67+/-cm bore diameter. High field EPI applications require oscillation rates at 1 kHz and higher. To achieve a benchmark 0.2 ppm shim over a 30cm sphere in a high field magnet, at least four stages of shimming need to be considered. 1) A good high field magnet will be built to a homogeneity spec. falling in the range of 100 to 150 ppm over this 30cm spherical "sweet spot" 2) Most modern high field magnets will also have superconducting shim coils capable of finding 1.5 ppm by their adjustment during system installation. 3) Passive ferro-magnetic shimming combined with 4) active, high order room temperature shim coils (as many as five orders are now being recommended) will accomplish 0.2 ppm over the 30cm sphere, and 0.1 ppm over a human brain in even the highest field magnets for human studies. Safety concerns for strong, fast gradients at any B0 field include acoustic noise and peripheral nerve stimulation. One or more of the mechanical decoupling methods may lead to quieter gradients. Patient positioning relative to asymmetric or short gradient coils may limit peripheral nerve stimulation at higher slew rates. Gradient designs combining a short coil for local speed and strength with a longer coil for coverage are being developed for 3T systems. Local gradients give another approach to maximizing performance over a limited region while keeping within the physiologically imposed dB0/dt performance limits.

  • PDF

소아기 류마티스모양 관절염 환자에서 etanercept 사용 후 발생한 뇌염 1예 (A case of encephalitis in a juvenile rheumatoid arthritis patient treated with etanercept)

  • 권아름;;김기환;김동수
    • Clinical and Experimental Pediatrics
    • /
    • 제53권2호
    • /
    • pp.262-266
    • /
    • 2010
  • $TNF-{\alpha}$ 는 소아기 류마티스모양 관절염의 병태생리학에 관여하는 주요 cytokine 이다. Etanercept 는 $TNF-{\alpha}$ 억제제 중 하나로 소아기 류마티스모양 관절염에 효과적인 약물로 각광받고 있다. Etanercept의 주요 부작용은 면역력 저하에 의한 감염으로, 대게 중등도의 상기도 감염이 대부분으로 알려져 있으나, 최근 중증의 감염도 보고되고 있다. 저자들은 소아기 류마티스모양 관절염 환자가 etanercept를 14개월간 투약 후 발생한 뇌염 1예를 경험하였기에 보고하는 바이다.

Phelan-McDermid syndrome presenting with developmental delays and facial dysmorphisms

  • Kim, Yoon-Myung;Choi, In-Hee;Kim, Jun Suk;Kim, Ja Hye;Cho, Ja Hyang;Lee, Beom Hee;Kim, Gu-Hwan;Choi, Jin-Ho;Seo, Eul-Ju;Yoo, Han-Wook
    • Clinical and Experimental Pediatrics
    • /
    • 제59권sup1호
    • /
    • pp.25-28
    • /
    • 2016
  • Phelan-McDermid syndrome is a rare genetic disorder caused by the terminal or interstitial deletion of the chromosome 22q13.3. Patients with this syndrome usually have global developmental delay, hypotonia, and speech delays. Several putative genes such as the SHANK3, RAB, RABL2B, and IB2 are responsible for the neurological features. This study describes the clinical features and outcomes of Korean patients with Phelan-McDermid syndrome. Two patients showing global developmental delay, hypotonia, and speech delay were diagnosed with Phelan-McDermid syndrome via chromosome analysis, fluorescent in situ hybridization, and multiplex ligation-dependent probe amplification analysis. Brain magnetic resonance imaging of Patients 1 and 2 showed delayed myelination and severe communicating hydrocephalus, respectively. Electroencephalography in patient 2 showed high amplitude spike discharges from the left frontotemporoparietal area, but neither patient developed seizures. Kidney ultrasonography of both the patients revealed multicystic kidney disease and pelviectasis, respectively. Patient 2 experienced recurrent respiratory infections, and chest computed tomography findings demonstrated laryngotracheomalacia and bronchial narrowing. He subsequently died because of heart failure after a ventriculoperitoneal shunt operation at 5 months of age. Patient 1, who is currently 20 months old, has been undergoing rehabilitation therapy. However, global developmental delay was noted, as determines using the Korean Infant and Child Development test, the Denver developmental test, and the Bayley developmental test. This report describes the clinical features, outcomes, and molecular genetic characteristics of two Korean patients with Phelan-McDermid syndrome.

Microvascular Decompression for Hemifacial Spasm Associated with Vertebrobasilar Artery

  • Kim, Joo-Pyung;Park, Bong-Jin;Choi, Seok-Keun;Rhee, Bong-Arm;Lim, Young-Jin
    • Journal of Korean Neurosurgical Society
    • /
    • 제44권3호
    • /
    • pp.131-135
    • /
    • 2008
  • Objective : Hemifacial spasm (HFS) is considered as a reversible pathophysiological condition mainly induced by continuous vascular compression of the facial nerve root exit zone (REZ) at the cerebellopontine angle. As an offending vessel, vertebrobasilar artery tends to compress much more heavily than others. The authors analyzed HFS caused by vertebrobasilar artery and described the relationships between microsurgical findings and clinical courses. Methods : Out of 1,798 cases treated with microvascular decompression (MVD) from Jan. 1980 to Dec. 2004. the causative vessels were either vertebral artery or basilar artery in 87 patients. Seventy-nine patients were enrolled in this study. Preoperatively, computed tomography (CT) or brain magnetic resonance (MR) imaging with 3-dimentional short range MR technique was performed and CT was checked immediately or 2-3 days after anesthetic recovery. The authors retrospectively analyzed the clinical features. the compression patterns of the vessels at the time of surgery and treatment outcomes. Results : There were 47 were male and 32 female patients. HFS developed on the left side in 52 cases and on the right side in 27. The mean age of onset was 52.3 years (range 19-60) and the mean duration of symptoms was 10.7 years. Many patients (39 cases; 49.1%) had past history of hypertension. HFS caused only by the vertebral artery was 8 cases although most of the other cases were caused by vertebral artery (VA) in combination with its branching arteries. Most frequently, the VA and the posterior inferior cerebellar artery (PICA) were the simultaneous causative blood vessels comprising 32 cases (40.5%). and in 27 cases (34.2 %) the VA and the anterior inferior cerebellar artery (AICA) were the offenders. Facial symptoms disappeared in 61 cases (77.2%) immediately after the operation and 68 cases (86.1%) showed good outcome after 6 months. Surgical outcome just after the operation was poor in whom the perforators arose from the offending vessels concurrently (p<0.05). Conclusion : In case where the vertebral artery is a cause of HFS, commonly branching arteries associated with main arterial compression on facial REZ requires more definite treatment for proper decompression because of its relatively poor results compared to the condition caused by other vascular compressive origins.

기능적 자기공명영상을 이용한 단기기억 뇌기능 매핑연구 (Working Memory Mapping Analysis using fMRI)

  • 주라형;최보영;서태석
    • 한국의학물리학회지:의학물리
    • /
    • 제16권1호
    • /
    • pp.32-38
    • /
    • 2005
  • 작동기억 및 얼굴 영상에 대한 정보 처리 과정의 장애는 정신분열병 환자에서 나타나는 광범위한 인지기능 장애 중의 하나이다. 본 연구는 기능적 자기공명영상기법을 이용하여 정신분열병 환자군과 정상 대조군 간의 얼굴 영상의 작동기억에 관여하는 뇌 활성의 차이를 분석하고자 하였다 10명의 정신분열병 환자와 10명의 정상 대조군을 대상으로 선정하였다. 얼굴영상 자극을 이용한 1-back 작동기억 파라다임을 수행하는 동안 뇌 피질의 활성을 측정하기 위해 기능적 자기공명영상으로 두 군간의 뇌 활성의 차이를 SPM을 사용하여 분석하였다. 정신분열병 환자군은 정상대조군에 비해 작동기억 수행 점수가 유의하게 저하되어 있었다 환자군에서 대뇌의 좌측 방추상 이랑, 우측 위 전두 이랑, 양측 중간 전두 이랑, 도, 좌측 중간 측두 이랑, 설전부 피질과 소뇌의 사각엽과 충부의 활성이 감소되어 있었다. 반면, 외측 전전두 피질과 두정엽의 활성이 증가되었고, 또한 두 군 모두에서 우측반구의 활성이 증가되어 있었다. 정신분열병 환자에서 좌측 방추상 이랑의 활성이 감소된 것은 얼굴 영상에 대한 정보 처리 과정의 장애를 의미하며 기능적 자기공명영상분석법으로 작동기억능력의 유용성을 평가하였다.

  • PDF